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The aim of this study was to quantify bisphenol A (BPA) concentrations in saliva
and urine before and after treatment with dental polymer-based restorative materi-
als to assess if placement of this material is associated with increased BPA levels in
saliva and urine. Twenty individuals in need of at least one dental restoration with
polymer-based restorative material were included in this study. The participants
were instructed to abstain from eating, drinking, and brushing their teeth for at
least 10 h prior to sampling. Saliva and urine were collected before and 10 min (sal-
iva only), 1 h, 24 h, and 1 wk after treatment. Samples were stored at 80°C before
analyses. BPA in saliva and urine was determined with liquid chromatography/mass
spectrometry. Linear mixed effects regression models were used for statistical analy-
ses. There was a statistically significant increase of salivary BPA concentration
directly after placement of the dental polymer-based restorations. Following place-
ment, the concentration of BPA decreased exponentially with time. One week after
treatment the BPA level in saliva was only marginally higher than before treatment.
In urine, no statistically significant change of the BPA concentration was detected
after treatment.
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Bisphenol A (BPA; CAS no. 80-05-7) is a synthetic
chemical substance, produced in large quantities and
widely used in the production of polycarbonate plastics,
epoxy resins, dental monomers, thermal paper, and
numerous other products (1). Bisphenol A is known as
an endocrine disruptor with the ability to interfere with,
and mimic, estrogenic hormones (2–4). Concern has
been raised about low-level exposure to BPA and the
possible association with adverse health effects. In-vitro
and animal studies have linked BPA exposure to a vari-
ety of negative outcomes (5). In several epidemiological
studies, BPA levels in human populations have been
associated with reproductive abnormalities, adverse
developmental effects, metabolic disease, and breast can-
cer, among other health conditions (6–8). Although these
findings are controversial (9), the current opinion of
risk-assessment agencies, such as the European Food
Safety Authority (EFSA), is that negative health effects
from BPA exposure cannot be excluded (10). Of greatest
concern is potential exposure during vulnerable periods,
such as fetal and early postnatal development (4). In
humans, the free (unconjugated) estrogenic form of BPA
generally is conjugated to a non-estrogenic form via ‘the
first pass metabolism’ in the liver and is eliminated in
urine (11). However, the ability to metabolize and
excrete BPA from the body may not be fully developed
in the fetus and the neonate (12). In January 2015, the
EFSA revised the recommended limit of ‘tolerable daily
intake’ of BPA from 50 to 4 lg kg1 of bodyweight per
day (10) and in December 2017 the European Chemicals
Agency reclassified BPA as a chemical of very high con-
cern (13). In November 2018, a working group from the
EFSA started re-evaluating the potential hazards of
BPA in food based on studies and data published after
2012. This new assessment is expected to be completed
in 2020 (https://www.efsa.europa.eu/en/press/news/
180904, downloaded 22.02.2019).
There is wide interest in the sources of BPA expo-
sure. The primary source of human exposure is
assumed to be through the diet because BPA can leach
into food and beverages from containers made of poly-
carbonate plastic or lined with epoxy resin coatings
(1, 14, 15). However, results from studies have indi-
cated human exposure also from numerous non-dietary
sources, including dust and indoor air, thermal paper,
cosmetics, and dental materials (1, 10, 15, 16).
In dentistry, BPA is used as a raw material in the syn-
thesis of several resin monomers and may be found as an
impurity in dental materials (17). The most frequently
used monomers synthesized from BPA include bisphenol
A glycidyl methacrylate (Bis-GMA; CAS no. 1565-94-2),
bisphenol A ethoxylate dimethacrylate (Bis-EMA,
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CAS no. 41637-38-1), and bisphenol A dimethacrylate
(Bis-DMA; CAS no. 3253-39-2) (18, 19). It has been
shown that Bis-DMA-based materials, such as Delton
LC fissure sealant (Ash/Dentsply, York, PA, USA), may
release BPA as a result of hydrolysis at the ester bond
(20), whereas Bis-GMA-based materials, which typically
comprise restorative materials, do not undergo this form
of biodegradation because its ether bond is resistant to
hydrolysis (20–24). Several in-vitro and some in-vivo
studies have focused on BPA leakage from dental poly-
mer-based filling materials and have attempted to quan-
tify the amounts detected in different solutions or
biological media (17, 19, 25–30). However, the amounts
reported vary, probably because of differences in the
materials examined and the methodological approaches
(19, 31). Moreover, exposure from other sources, e.g.,
participants’ diet and its contribution to the BPA con-
centration in biological samples (e.g., urine), has not
been thoroughly considered in previous clinical studies.
The aim of this study was to quantify BPA concen-
trations in saliva and urine, before and after treatment
with dental polymer-based restorative materials, to
assess if placement of these materials is associated with
increased BPA levels in saliva and urine.
Material and methods
Study population
Patients in need of at least one dental restoration, involving
two or more tooth surfaces, with a polymer-based restora-
tive material were informed about the study by their dental
hygienist or dentist at their regular dental examination at
two public dental clinics in Bergen, Norway. Patients who
chose to participate were given written information about
the study for perusal at home. Individuals with removable
dentures, dental splints, and those who currently were
undergoing orthodontic treatment were excluded. Smokers,
snuff users, and drug abusers were also excluded. We did
not include individuals who had received polymer-based
dental fillings during the previous 3 months, dental stu-
dents, and dental health workers. Twenty volunteers, aged
between 16 and 40 yr, without any known diseases or medi-
cations at the time of the study, were included in the study
from January 2016 to November 2017. All participants pro-
vided written informed consent.
Ethical approval
All procedures involving human participants were per-
formed in accordance with the ethical standards of the
1964 Helsinki declaration and its later amendments, or
comparable ethical standards. The study protocol was
reviewed and approved by The Regional Committee for
Medical Research Ethics, South-East Norway (reference
number 2014/1529). The study is registered at Clinical-
Trials.gov (no.: NCT02575118).
Dental treatment procedures
One dentist (TLLB) recorded the number of tooth surfaces
previously filled with tooth-colored restorative materials.
The same dentist (TLLB) provided the dental treatment at
a public dental clinic in Bergen, Norway. The treatment
was performed according to standardized procedures and
materials used at the clinic. Local anesthesia (Xylocain
Dental adrenalin; Dentsply, Weybridge, UK) was used in
19 of the participants; one participant preferred treatment
without anesthesia. Cavity preparations were performed
with diamond burs (Horico, Berlin, Germany) and round
steel burs (Meisinger, Neuss, Germany). Cotton rolls and
low-volume evacuator equipment (Hygoformic Saliva Ejec-
tor; Orsing, Helsingborg, Sweden) were used for moisture
control. High-volume evacuator equipment (Hygovac aspi-
rator tube; Orsing) was used during cavity preparations
and etching, bonding, and finishing procedures. Rubber
dam isolation was not used. Contoured anatomical steel
matrices (Polydentia, Mezzovico, Switzerland) were used
to support and shape the restorations in premolars/molars,
and transparent curved strips (Hawe Neos; Kerr, Orange,
CA, USA) were used in front teeth. To create a tighter
seal, preventing gingival overhang, dental approximal
wooden wedges (Hawe Sycamore; Kerr) were used in all
cases. Etching with 37% phosphoric acid (ANA Etching
Gel 37%; Directa, Upplands V€asby, Sweden) was per-
formed according to the principles of the total-etch tech-
nique (32). A two-part primer adhesive system (OptiBond
FL; Kerr) was used as the bonding agent. The cavities
were restored with a widely used filling material (Tetric
EvoCeram, 0.2 g compules, Color A2, LOT 14504; Ivoclar
Vivadent, Schaan, Liechtenstein), tested to be assured it
was Bis-GMA-based. The bonding procedure and the
application of filling material were carried out according
to the manufacturers’ instructions. For each participant, a
new compule with filling material was used. The material
was applied in incremental layers of <2.0 mm, and each
layer was cured for 20–30 s. Care was taken to avoid
application of excessive amounts of material. Any surplus
was removed and put back into the compule. Each com-
pule was weighed before and after treatment, using an
analytical balance (AG204 DeltaRange; Mettler Toledo,
Greifensee, Switzerland). The amount (weight in g) of
polymer-based material used in each participant was esti-
mated by the difference between the two measurements.
The curing lamp (Satelec Mini LED; Aceton, Meriganac,
France) emitted 600–700 mW cm2 light intensity at a
range of 440–460 nm. The lamp was controlled prior to
each treatment using a hand-held curing radiometer
(Model 100, Dementron; Kerr, Danbury, CT, USA). After
curing, the fillings were polished according to standard
procedures using polishing diamond burs (Foss Viking,
Fetsund, Norway), polishing disks (Sof-Lex XT Pop; 3M
Espe, St Paul, MN, USA), and silicone polishers (Idento-
flex Composite Polisher; Kerr, Bioggio, Switzerland).
The restorations differed in size depending on the tooth
size and the extent of the prepared lesion. To adjust for
differences, each filling surface was given scores from 1 to
3, depending on its area (33). Small restorations were
given the lowest score of 1. Restorations of intermediate
size, typically the approximal or occlusal surfaces of Class
II restorations in premolars, were given a score of 2. The
highest score, 3, was used for molars to denote restora-
tions extending over the total occlusal fissure pattern or
over the approximal surface of Class II restorations. The
scores for all polymer-based filling surfaces treated in each
patient were summed and yielded the variable ‘filling
points’. The tooth surfaces treated and the estimated ‘fill-
ing points’ were recorded.
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Sample collection
All treatment sessions were scheduled in the morning
before 9 AM. Prior to the treatment, the participants were
asked about their dental hygiene habits and if they had
work that involved handling of receipts (thermal paper).
Each participant provided a total of five saliva samples
and four urine samples. The first saliva and urine samples
were collected immediately before treatment, after a 10-h
fast. Sampling of a second saliva sample was started
10 min after placement of the polymer-based fillings, and
subsequent saliva and urine samples were collected 1 h,
24 h, and 1 wk after placement of the fillings (Fig. 1). On
each day of sampling, the participants also answered ques-
tions regarding consumption of canned and microwaved
food during the previous week and within the previous
24 h. To reduce exposure from other potential sources of
BPA, the participants were instructed to abstain from eat-
ing, drinking, and brushing their teeth for at least 10 h
prior to sampling. Only tap-water was allowed for drink-
ing. The participants were asked not to use lip balm or lip-
stick during the same period. To identify possible
contamination during sampling, transport, and storage,
field blanks were collected using ultra-pure water (Synergy
Water Purification Systems; Millipore, Billerica, MA,
USA) instead of saliva and urine. The field blanks were
treated like the biological samples in all aspects.
For saliva sampling, the participants were sitting in a
relaxed position in the dental unit chair. They were
instructed to spit into the dental unit sink, but not to rinse
their mouth. Immediately afterwards, they were instructed
to perform active tongue and cheek movements for 60 s
and then to spit the accumulated saliva into a polypropy-
lene tube (15 ml, order number 62.554.001; Sarstedt,
N€umbrecht, Germany) until about 2 ml of saliva had been
sampled. To avoid contamination from the ambient air,
participants were asked to put the cap back on the tube
between each spit. The sampling time was recorded.
As the first morning urine void should not be collected,
the participants were instructed to empty their bladder in
the morning at home before entering the clinic. Urine
specimens were collected in 100-ml polypropylene cups
(order number 75.562.300; Sarstedt), and aliquots were
transferred into 15-ml polypropylene tubes. Immediately
after collection, the samples were refrigerated (at 4°C) and
within the same day were stored frozen at 80°C until
they were sent for analysis.
Determination of BPA in saliva and urine
Urine and saliva samples were analyzed at the laboratory
of the Division of Occupational and Environmental Medi-
cine at Lund University, Sweden, using liquid chromatog-
raphy-triple quadrupole mass spectrometry (LC/MS/MS;
QTRAP 5500; AB Sciex, Foster City, CA, USA). Saliva
samples were analyzed using a method described by BERGE
et al. (34), and urine samples were analyzed using a modi-
fied method described by GYLLENHAMMAR et al. (35).
Briefly, for the determination of total BPA in saliva, 100-ll
aliquots of saliva were digested with 10 µl glucuronidase
added with 1 ng of isotopically labeled internal standard
for BPA (D16-BPA), and proteins were precipitated using
acetonitrile. Free (unconjugated) BPA in saliva was deter-
mined without using glucuronidase. For the analysis of
total BPA in urine samples, aliquots of 200 ll were digested
with 10 µl glucuronidase and added with 1 ng D16-BPA.
The concentration of BPA in urine was adjusted for urinary
density (36). Two different in-house prepared quality con-
trol (QC) samples and chemical blanks were analyzed in the
analytical batches. The limit of detection (LOD) was deter-
mined to be 0.1 ng ml1. The method had acceptable
between-day and within-run precision. The laboratory used
is a European reference laboratory for BPA in urine (http://
www.eu-bm.info/democophes) and a reference laboratory
for BPA in urine in the Erlangen Round Robin inter-labo-
ratory control program. A detailed description of the ana-
lytical method is given in Appendix S1.
Statistical method
Continuous variables were summarized using mean values,
minimum and maximum values, and standard deviations
(SDs), whereas categorical variables were described using
frequencies. For analyses of repeated measures for saliva
and urine samples, linear mixed-effects regression models
were applied. In the mixed-effects model, the repeated nat-
ure of the measurements of the data was accounted for
Fig. 1. Time schedule of saliva (S) and urine (U) sampling.
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using the patient ID, entered as a random factor, with an
additional factor for time to account for the difference in
variation (SD) over time.
Time point when a measurement was made was entered
as a categorical variable in the models, comparing the suc-
ceeding measurements with the baseline (before treatment)
measure. All available data, and hence data for partici-
pants with missing observations at some time points, were
included in the model.
The decrease over time of the mean posttreatment BPA
concentration in saliva was described using the equation:
Y = aXb, where Y is the BPA concentration and X is time.
The equation was estimated by applying mixed-effects
regression on a log transform of the equation (which
transforms the equation to a linear model).
For the descriptive statistics, SPSS for Windows (IBM
Corp, Version 25, Armonk, NY, USA) was applied, while
STATA for Windows (StataCorp, LLC., Version 15, College
Station, TX, USA) was used for the mixed-effect analyses.
Bisphenol A values below the LOD were set to one half of
the LOD in the statistical analysis (37). Values of P <0.05
were considered to indicate statistical significance.
Results
Background and dental treatment characteristics
Background characteristics of the participants are
shown in Table 1. Data regarding dental hygiene habits
and consumption of canned and microwaved food are
listed in Table 2. Details regarding dental treatment are
shown in Table 3. Three of the participants attended
the study without having any pre-existing polymer-
based dental fillings, and nine participants had poly-
mer-based fillings removed during treatment.
Concentration of BPA in saliva
The saliva samples collected 10 min after treatment
showed a statistically significant increase in BPA levels
compared with the pretreatment samples. The
concentrations remained significantly elevated 1 h, 24 h,
and 1 wk after placement (Table 4; Fig. 2). After the
immediate post-treatment increase, the concentration of
BPA in saliva (Y; ng ml1) decreased exponentially. We
estimated the relationship between the decrease and time
(X; h) to be Y = 54.2X1.12 (Fig. 3). In saliva, no conju-
gated BPA was detected. Pretreatment levels of BPA in
saliva were low, and the mean value was estimated to be
0.11 ng ml1 (Table 4). Before treatment, 11 (55%) of
Table 1





Mean (SD) 23.4 (5.7)
Min-Max 17–36
Education (yr)
Mean (SD) 13.8 (1.8)
Min-Max 10–17
Daily use of chewing gum
Yes/No 4/16
Daily use of toothpaste
Yes/No 20/0




Max, Maximum; Min, Minimum.
Table 2
Data regarding participants’ dental hygiene habits and intake of
canned and microwaved food, stratified according to sampling











Refrained from food and
drink at least 10 h
before sampling
Yes/No 20/0 20/0 19/1
Brushed teeth during the
morning before
sampling
Yes/No 5/15 2/18 2/18
Use of mouthrinse before
sampling
Yes/No 1/19 1/19 0/20
Intake of canned food
last 24 h
Yes/No 4/16 2/18 4/16
Intake of microwaved
food last 24 h
Yes/No 2/18 2/18 1/19
Intake of canned food
last week
Yes/No 13/7 NA 12/8
Intake of microwaved
food last week
Yes/No 7/13 NA 2/18
NA, not applicable.
Table 3
Data regarding previous and current dental restorative treat-
ment of the participants (n = 20)
Variables Mean (SD) Min Max
Number of pre-existing tooth-
colored filling surfaces
11.8 (9.6) 0 26
Number of pre-existing tooth-
colored filling points
25.7 (21.7) 0 68
Number of polymer-based filling
surfaces removed during treatment
0.70 (0.92) 0 3
Number of polymer-based filling
points removed during treatment
1.8 (2.7) 0 9
Number of treated filling surfaces 3.7 (1.9) 2 10
Number of treated filling points 7.7 (0.7) 4 15
Weight of polymer-based material
used (g)
0.158 (0.067) 0.065 0.309
Max, Maximum; Min, Minimum.
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20 participants had salivary BPA levels below the limit
of detection (0.1 ng ml1). In one saliva sample collected
before treatment, the BPA concentration was more than
100 times higher (11.6 ng ml1) than the mean value and
more than 100 SD from the mean of the remaining 19
samples. This saliva sample was excluded from the statis-
tical analysis because it was probably contaminated. One
participant had breakfast before the sample time point
1 wk after treatment, and thus the samples collected
from this participant at this time point were not included
in the statistical analysis.
The levels of BPA concentrations in saliva were con-
firmed by analyzing nine samples using LC-MS/MS at
an independent laboratory (Nordic Institute of Dental
Materials, Oslo, Norway). These samples were selected
to represent the full range of the values from the labo-
ratory in Lund. The interclass correlation was high
(0.91; 95% CI: 0.72–0.98), which indicates strong agree-
ment between the measurements.
Secondary explorative analysis showed that the num-
ber of filling points was associated with the BPA levels
in saliva, 24 h (P = 0.011) and 1 wk (P = 0.029) after
treatment. However, neither the number of filling sur-
faces nor the amount (weight) of dental polymer-based
material placed was associated with the salivary BPA
concentration at any time point (all P > 0.05). More-
over, there were no statistically significant associations
between the other covariates tested and the salivary
BPA levels at the different time points (see Tables 1–3
for tested variables).
Concentration of BPA in urine
Table 4 presents density-adjusted concentrations of
BPA in urine before and after treatment. Before treat-
ment, 19 (95%) of 20 participants had detectable levels
of BPA in their urine. There were no statistically signif-
icant differences between urinary BPA levels before and
Table 4
Estimated bisphenol A (BPA) concentration (ng ml1) in saliva and urine samples before and after treatment with polymer-based
dental restorative material
Biological matrix Time point N Mean 95% CI P value
Saliva Before treatment 19 0.11 <LOD–0.16 Reference
10 min after treatment 20 385 205–565 <0.001
1 h after treatment 20 88.2 42.4–134 <0.001
24 h after treatment 20 1.85 0.72–2.98 0.003
1 wk after treatment 19 0.25 0.17–0.33 0.002
Urine* Before treatment 20 1.41 0.42–2.41 Reference
1 h after treatment 20 1.17 0.18–2.16 0.674
24 h after treatment 20 1.53 0.54–2.53 0.834
1 wk after treatment 19 1.99 0.97–3.00 0.321
Limit of detection (LOD) = 0.1 ng ml1, values <0.1 ng ml1 were set to half of the LOD.
*Density-adjusted urine concentrations (1.016 g l1).
Fig. 2. Salivary concentrations (ng ml1) of bisphenol A
(BPA) among participants (individual patterns are shown)
before treatment (baseline), and 10 min, 1 h, 24 h, and 1 wk
after treatment with polymer-based filling material (n = 20).
Fig. 3. Concentration (ng ml1) of bisphenol A (BPA) in sal-
iva after treatment with dental polymer-based restorative
materials as a function of time (h).
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after placement of the dental polymer-based restora-
tions (Table 4; Fig. 4). The BPA levels in the urine
samples collected 1 h after treatment did not show a
statistically significant association with the BPA level in
the saliva samples collected 10 min after treatment
(data not shown).
Figure 4, presenting the urinary BPA levels over
time, illustrates that two of the participants showed
considerably higher BPA levels than the others. One of
these participants had higher BPA levels at all time
points, while the other only had an elevated BPA con-
centration at the 1-wk time point. These participants
were identified as being two of five participants who
handled cash register receipts at work. The participant
with highest levels in urine was also the one with the
highest levels of BPA in saliva at all time points. Using
receipts as a group variable (yes, n = 5/no, n = 15) we
found an overall elevated average level of urinary BPA
in the group of participants who handled receipts
(P = 0.031, mean difference 0.83 ng ml1; 95% CI:
0.08–1.57).
Regression models testing additional potential factors
that could contribute to the BPA concentration in urine
(see Tables 1–3 for tested variables) did not show a sta-
tistically significant influence at any time point (all
P > 0.05).
All field blanks had BPA concentrations below the
detection limit.
Discussion
There was a considerable increase in the BPA concen-
tration in saliva directly after placement of a dental
polymer-based dental restorative material. The concen-
tration of BPA then decreased exponentially with time.
One week after treatment the concentration of BPA
in saliva was only marginally higher than before
treatment. This is in agreement with the results from
other studies of BPA leakage from existing polymer-
based fillings (29, 34). The time-course of the salivary
BPA concentration after treatment is in accordance
with other studies and supports a plausible pattern,
which suggests that the main exposure to BPA from
polymer-based dental filling materials is limited to a
short period after placement (21, 26, 38, 39). In urine,
no change of the BPA concentration was detected after
treatment.
In the last two decades, the amounts of BPA present
in saliva and urine after placement of dental polymer-
based materials have been examined in several studies
(26, 28, 30, 39). However, there are wide differences in
the materials tested regarding composition, brands, and
application modes. Moreover, the size and number of
tooth surfaces filled, sampling procedures, measurement
time points and intervals, analytical methods, sensitivity
of methods, and detection limits differ between studies.
These differences may account for diverging results,
which make comparison between studies and calcula-
tions of the actual amounts released difficult (19, 31).
KLOUKOS et al. (31), when searching the literature to
assess the short- and long-term release of BPA in
human tissues after treatment with dental sealants, con-
cluded that only qualitative evaluation may be per-
formed.
In the present study, the mean BPA concentration
detected in saliva immediately after treatment was
higher than expected. Our results are comparable with
previous studies assessing salivary BPA concentrations
directly after (21) and 1–3 h after (38) placement of a
Bis-DMA-based dental fissure sealant (Delton LC). The
range in BPA concentrations from these studies was
0.3–2.8 ppm and 5.8–105.6 ppb, respectively. OLEA
et al. (25) reported that the cumulative salivary BPA
concentration 1 h after sealant placement was approxi-
mately 100 times higher than the BPA concentration
detected directly after treatment in our study. However,
the reliability of the analytical method used by OLEA
et al. has been questioned (22) and the levels have not
been confirmed by later studies. Other authors have
evaluated the release of BPA in saliva after placement
of Bis-GMA-based dental materials used as restoratives
(26, 29, 40, 41) and in orthodontic treatment, bonding
lingual retainers (28), or brackets (30, 42). The salivary
BPA levels reported in these studies are considerably
lower than the levels reported in the present study.
The potential of dental polymer-based restorative
materials to release BPA may differ depending on the
BPA derivatives included in the material. Because of
the hydrolysis of Bis-DMA, the BPA concentration in
saliva collected directly after treatment with Bis-DMA-
based materials is expected to be higher than the
amount of BPA found in salivary samples collected
directly after placement of Bis-GMA-based material
(22, 24). However, the wide divergence in the salivary
BPA concentration reported may have other explana-
tions. The source of BPA in Bis-GMA-based materials
includes residual BPA present in the raw materials used
in the manufacturing process (43). The amount of BPA
Fig. 4. Urinary concentrations (ng ml1) of bisphenol A
(BPA) among participants (individual patterns are shown)
before treatment (baseline), and 1 h, 24 h, and 1 wk after
treatment with polymer-based filling material (n = 20).
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remaining after the synthesis of Bis-GMA may vary
between different producers. A notable batch-to-batch
variation could also be expected if different raw materi-
als are used (43).
The release of components from dental polymer-
based materials after curing could be a consequence of
incomplete polymerization (44). During the polymeriza-
tion process, most of the monomers should be con-
verted into polymers to form a polymer network.
However, the degree of conversion is reported never to
be complete (45, 46). The extent to which monomers
are converted may be influenced by several factors,
including the curing time, the light intensity, the com-
position of the polymer-based material, and the thick-
ness of the incremental layer (47). In the present study,
the dental polymer-based material was placed in layers
and cured according to the manufacturer’s instructions.
No association was found between the amount (weight)
of material placed and salivary BPA concentration.
This finding is in agreement with other studies and may
be explained by the observation period used in the pre-
sent study, which was too short to allow degradation
and subsequent release of unbound compounds trapped
in the polymer network (17). However, the exposure of
materials to air inhibits polymerization and leads to a
thin, liquid layer on the filling surface (48, 49). From
this layer, uncured components have the potential to
leak immediately into the oral environment for a short
period of time (17). Some studies have indicated that
the release of BPA from dental polymer-based fillings
depends on the extent of the exposed filling surface (50,
51). Our study found no association between the sur-
face area of the polymer-based material placed and the
salivary BPA levels immediately after and 1 h after
treatment. However, 24 h and 1 wk after treatment, the
BPA concentration was associated with the number of
filling points.
Moisture control during restorative dental treatment
may include cotton rolls and a rubber dam combined
with a saliva ejector. It has been reported that the
increase in salivary BPA concentrations directly after
placement of dental polymer-based material may be
lower when a rubber dam is used (26); however, studies
indicate that most dentists do not use rubber dam iso-
lation during operative dentistry procedures (52, 53).
We expected the leakage of BPA from newly placed
polymer-based fillings to be low, so in an effort to per-
form the most commonly used clinical procedures and
detect the maximum amount of BPA released after
treatment, a rubber dam was not used during treatment
in our study. Immediately after treatment, the partici-
pants were instructed to spit once into the unit sink.
They then performed cheek and tongue movements and
consecutively spat the accumulated saliva into tubes.
Neither rinsing nor gargling was allowed before saliva
sampling. Thus, the saliva samples collected immedi-
ately after treatment in our study may include BPA
exposure from the uncured layer as well as surplus
material from the grinding and polishing procedure.
Probably the association between surface area (filling
points) and BPA concentration immediately after
treatment would have been stronger if gargling had
been permitted. Rinsing the mouth with water for 30 s
after polymer-based filling placement has been shown
to decrease the BPA concentration in saliva to nearly
baseline levels (41). In some studies, it was not reported
whether the participants were instructed to rinse their
mouth before sampling. Moreover, the time interval
reflecting ‘immediately after treatment’ may vary from
5 to 60 min across studies (26, 28, 29). Thus, the varied
sampling procedures could influence the differences in
the BPA concentrations detected and complicate esti-
mation of the amount of BPA released immediately
after treatment.
Clinical studies examining the saliva concentration of
leachable chemicals from dental polymer-based materi-
als show generally wide variations between participants
and the relative SD is usually high (25, 41, 54). Thus,
the homogeneity and representativeness of the saliva
samples could be questioned (55).
In the present study, the participants were instructed
to refrain from food and beverage intake for 10 h
before sample collection. Urine samples were collected
prior to treatment and 1 h, 24 h, and 1 wk after treat-
ment. The salivary BPA concentrations detected imme-
diately after treatment were high and could be expected
to be reflected in the subsequent urinary BPA concen-
trations. However, neither the first post-treatment urine
samples (collected 1 h after treatment), nor any other
post-treatment samples showed significant increases in
BPA concentrations compared with pretreatment levels.
This is in contrast to the findings by JOSKOW et al.
(39), which indicated that urinary BPA levels were
highest 1 h after sealant placement. Over time, there is
a large variation of BPA in urine (56), and intake of
food has a considerable influence on the concentration
of BPA in urine (57). Thus, it could be speculated that
the elevated urinary concentrations 1 h after treatment,
as reported in other studies, may have been influenced
by food intake before treatment. However, 10 h of fast-
ing may decrease the BPA exposure, and subsequently
the urinary BPA level, and thus partly mask a potential
increase in the urinary BPA concentration caused by
the dental treatment. The BPA concentration in urine
reflects the absorbed dose of BPA (58). Because saliva
samples were collected immediately after treatment, we
may have removed a significant amount of BPA, which
otherwise would have been absorbed, metabolized in
the liver, and excreted via the urine. Thus, saliva sam-
pling directly after treatment could have influenced the
BPA concentrations in urine considerably (39).
In the present study, we used LC/MS/MS with an
isotopically labeled internal standard (D16-BPA) for
the analysis of BPA. This is the method of choice for
measuring the content of BPA in biological samples
(59). Quality control samples and field blanks were ana-
lyzed together with the samples of saliva and urine. In
addition, a limited number of saliva samples were ana-
lyzed at a second laboratory and showed similar
results. Thus, we evaluated the analysis to be reliable
and the accuracy and precision acceptable for the pre-
sent purpose.
BPA in saliva and urine 441
To standardize the procedures as much as possible,
the dental treatment was provided by one dentist at
one dental clinic using the same procedures for all
patients. Moreover, the same batch of filling material
was used for all fillings.
The participants in the present study acted as their
own control, as reflected by pretreatment sampling.
Including an unexposed control group could have facil-
itated the interpretation of the contribution from the
polymer-based material to urinary BPA levels.
Although data from the study by JOSKOW et al. (39)
indicate an increase of BPA in urine 1 h after treat-
ment, it is possible that the peak concentration of BPA
in urine after exposure is between 1 and 4 h (58). Thus,
sample collection at 1 h may have been too early to
detect the maximum concentration of BPA in urine.
Two participants showed significantly higher urinary
BPA levels compared with the other participants
(Fig. 4). One had elevated BPA levels in urine at all
time points. Both participants handled receipts at work
and consequently thermal paper could be one source of
exposure to BPA. Regarding the group of participants
who handled receipts, there was substantial between-
and within-subject variability, but average levels were
elevated, as was also found by THAYER et al. (60).
There may be considerable differences regarding
potential BPA exposure, depending on the materials
used. Because only one batch of one material was
tested in this study, the amounts of BPA detected must
be interpreted with care. Materials with a lower level of
contamination with BPA may result in lower exposure.
Hence, the daily dose of BPA from dental polymer-
based restorative materials is probably relatively low
compared with the total exposure from food and other
sources (10). However, the biologic effects of BPA have
been reported to occur even within the range of the
detection threshold of most analytical procedures, and
its influence on tissues may show a non-monotonic
dose–response curve pattern (61). This is characterized
by intense reactivity at low levels and no response at
high levels (62).
Data on the chemical composition of dental poly-
mer-based material from the material Safety Data
Sheets are incomplete (19). Therefore, manufacturers
should be required to provide more exact information
about the composition of their products (19). Ideally,
dental polymer-based materials should be produced
without components that have estrogenic effects. How-
ever, materials introduced as BPA free have also shown
estrogenic activity (63). Thus, methods to reduce the
release of BPA after placement of dental polymer-based
materials should be provided. Using a rubber dam to
control the operative field would limit the potential
exposure (26). Moreover, rinsing with water directly
after treatment should be highly recommended (41).
In conclusion, the findings in this study confirm that
placement of dental polymer-based restorative materials
may cause a substantial increase in the concentration of
salivary BPA after treatment. The results indicate that
exposure to BPA is relatively short and transient. After
1 wk, the concentration of BPA in saliva was only
slightly elevated compared with the levels before treat-
ment. This study did not show changes in the BPA
concentration in urine after treatment with a dental
polymer-based restorative material.
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Additional Supporting Information may be found in the online
version of this article:
Appendix S1. Analysis of bisphenol A.
Fig. S1. Total ion chromatogram for the BPA peak from the stan-
dard sample of 50 ng/ml.
Fig. S2. Quadropole time of flight mass spectra for the BPA peak
from the standard sample of 50 ng/ml.
Fig. S3. Total ion chromatogram for the BPA peak from a saliva
sample with a concentration of 800 ng BPA/ml.
Fig. S4. Quadropole time of flight mass spectra for the BPA peak
from the saliva sample shown in Fig. S3.
444 Berge et al.
